PlatinolFound 9 free book(s)
Cisplatin DRUG NAME: Cisplatin SYNONYM: CDDP ,1 cis-Diamminedichloroplatinum 2dichlorodiammineplatinum(II) 3 Patinum II DDP 4 COMMON TRADE NAME: PLATINOL ®; -AQ. CLASSIFICATION: Platinum compound. 5. Special pediatric considerations are noted when applicable, otherwise adult provisions apply.
The active ingredient, cisplatin, is a yellow to orange crystalline powder with the molecular formula PtCl. 2. H. 6. N. 2, and a molecular weight of 300.1.
GR-69035 (4-18) Keytruda ® (pembrolizumab) Injectable Medication Precertification Request Page 2 of 5 (All fields must be completed and legible for Precertification Review.)
Appendix 1 Content Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers
3 . Others . thalidomide (Thalomid) Non-Steroidal Anti-inflammatory Drugs (NSAIDS) (Please see notation for NSAIDS under “hearing loss.”) •aspirin
Drugs With Special Ordering Procedures (SAP Chart) Drug Supplier BCCA Requirements Ordering Procedures. Abiraterone Janssen Ortho tel: 416-382-5078 or 416-805-
COG LTFU Guidelines Reference Materials – Page 4 Version 4.0 – October 2013 – Abbreviations Abbreviations Abbreviation Definition AAP-CIDP American Academy of Pediatrics Committee on Infectious Disease Prevention
HEAD AND NECK CANCERS TREATMENT REGIMENS (Part 2 of 2) REGIMEN DOSING Recurrent, Unresectable, or Metastatic (continued) Carboplatin + docetaxel1,13 Day 1: Docetaxel 65mg/m 2 1 hr IV infusion followed immediately by carboplatin AUC=6mg/mL/min IV infusion.
HANDLING CYTOTOXIC DRUGS INSTRUCTIONS Ansell Healthcare is a provider approved by the California Board of Registered Nursing, Provider # CEP 15538 for 2 contact hour(s).
DRUG NAME: Cisplatin, PLATINOL, Food and Drug Administration, Pembrolizumab) Injectable Medication Precertification Request, I Materials for Clinical Application of, Ototoxic Medications, Drugs With Special Ordering Procedures SAP Chart, Appendix I Materials, Materials, AND NECK CANCERS TREATMENT REGIMENS Part, HANDLING CYTOTOXIC DRUGS